JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Trichinellosis in the European union: epidemiology, ecology and economic impact.

Parasitology Today 1998 January
Trichinellosis, one of the most widespread helminthic zoonoses, is still endemic in most countries of the European Union. In the past few years, advanced biotechnology has been used to re-examine the taxonomy, epidemiology and life cycles of aetiological agents, providing additional information on the main factors contributing to the maintenance of these parasites in Nature. The old concept that pigs and rats are the main hosts of Trichinella spiralis, as still reported in many books, has been re-evaluated thoroughly. In this review, Edoardo Pozio summarizes the epidemiology and ecology of human and animal trichinellosis, quantifies the economic impact of this zoonosis and suggests methods of controlling this infection that would result in a great reduction in costs.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app